LLY Jun 2022 125.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.6400

0.0000

(0.00%)

As of 09:30AM EDT. Market open.

Loading interactive chart…

Zacks
Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update
Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.
Zacks
Pharma ETFs in Focus Post Q1 Earnings
Many industry bigwigs reported solid results with some beating on earnings or revenues or both.
Zacks
Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID
The FDA grants full approval to Lilly (LLY) and Incyte for COVID-19 in certain hospitalized adults. Olumiant is already authorized for emergency use for this indication since November 2020.